Notice of Intent to Award a Sole Source for Icad Ai Tender

• Country: USA
• Summary: Notice of Intent to Award a Sole Source for Icad Ai Mammography Software Licenses
• UST Ref No: 138946880
• Deadline: 12 Apr 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: HHS-OMAS-26-1519994
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Notice of Intent to award on a Sole Source Basis
  Title: Notice of Intent to Award a Sole Source for iCAD AI Mammography Software Licenses
  Notice Number: HHS-OMAS-26-1519994
  Agency: Department of Health and Human Services, Indian Health Service (IHS)
  Contracting Office: HHS - Office of Mission Acquisition Solutions
  Product Service Code (PSC): DA10 (IT and Telecom - Business Application/Application Development Software as a Service)
  NAICS Code: 513210 (Software Publishers)
  Place of Performance: Fort Belknap Hospital, 669 Agency Main St, Harlem, MT 59526
  Set Aside: Not Applicable (Sole Source)
  Response Date: 04/12/2026 1:00 PM MST
  Description
  This is a Notice of Intent to negotiate on a sole source bases for a firm-fixed-price purchase order to iCAD, Inc., 900 Kent Ave, Nashua, NH 03063.
  The Indian Health Service (IHS) has a requirement for the renewal and continuation of iCAD 2D/3D Detection Per Exam Licenses for its 3D Mammography (Digital Breast Tomosynthesis) suite.
  Requirement Details:
  The required service provides an essential Artificial Intelligence (AI) platform that serves as a concurrent reading tool to aid Radiologists in the interpretation of mammogram studies. The service includes critical software upgrades necessary to maintain the system-s diagnostic accuracy and security.
  The period of performance for this award is anticipated to be one 12-month base period with four 12-month options:
  Base Year: TBD Upon Award - Option Year 1: TBD - Option Year 2: TBD - Option Year 3: TBD - Option Year 4: TBD
  Justification for Sole Source:
  iCAD, Inc. is the only source capable of providing the required services for the following reasons:
  Proprietary Technology: The AI software is a proprietary program owned and developed exclusively by iCAD, Inc. Its specific, FDA-cleared deep-learning algorithm is unique intellectual property. No other vendor is licensed to sell, distribute, or provide the mandatory software upgr...
• Documents:

 Tender Notice